Download presentation
Presentation is loading. Please wait.
Published byDoris Atkins Modified over 8 years ago
1
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] by John G.F. Cleland, Jean-Claude Daubert, Erland Erdmann, Nick Freemantle, Daniel Gras, Lukas Kappenberger, and Luigi Tavazzi EHJ Volume 27(16):1928-1932 August 2, 2006 © The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
2
The Kaplan–Meier estimates of the time to all-cause mortality. John G.F. Cleland et al. Eur Heart J 2006;27:1928-1932 © The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
3
John G.F. Cleland et al. Eur Heart J 2006;27:1928-1932 © The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
4
John G.F. Cleland et al. Eur Heart J 2006;27:1928-1932 © The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
5
Effect of cardiac resynchronization on all-cause mortality in subgroups pre-defined by the main study analysis. John G.F. Cleland et al. Eur Heart J 2006;27:1928-1932 © The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.